Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study-Reference-Cited by-同舟云学术

Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study

Published:2021-05-03 Issue:7 Volume:96 Page:823-833
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Lam Marion¹²^ORCID,Touitou Valérie¹,Choquet Sylvain³,Cassoux Nathalie⁴,Ghesquières Hervé⁵,Kodjikian Laurent⁶⁷,Schmitt Anna⁸,Gattoussi Sarra⁹¹⁰,Tabouret Émeline¹¹¹²,Sampo Magali¹³,Blonski Marie¹⁴,Angioi‐Duprez Karine¹⁵,Houot Roch¹⁶,Mouriaux Frédéric¹⁷,Gyan Emmanuel¹⁸,Le Lez Marie‐Laure¹⁹,Moles Marie‐Pierre²⁰,Croisé Fabien²¹,Chauchet Adrien²²,Schwartz Claire²³,Ahle Guido²⁴^ORCID,Meyer Laurent²⁵,Gressin Rémy²⁶,Chiquet Christophe²⁷²⁸,Oberic Lucie²⁹^ORCID,Ollé Priscille³⁰,Marolleau Jean‐Pierre³¹,Jany Benjamin³²,Tempescul Adrian³³,Cochener Béatrice³⁴,Damaj Gandhi³⁵^ORCID,Quintyn Jean‐Claude³⁶,Moluçon‐Chabrot Cécile³⁷,Rousseau Eve³⁸^ORCID,Franciane Paul³⁹,Schneider Christelle⁴⁰,Massé Hélène⁴¹,Tamburini‐Bonnefoy Jérôme⁴²,Brézin Antoine⁴³,Fornecker Luc‐Matthieu⁴⁴^ORCID,Ballonzoli Laurent⁴⁵,Le Garff‐Tavernier Magali⁴⁶,Hoang‐Xuan Khê⁴⁷,Bodaghi Bahram¹,Soussain Carole⁴⁸⁴⁹,Houillier Caroline⁴⁷

Affiliation:

1. Ophthalmology, Assistance Publique – Hôpitaux de Paris (APHP) Groupe Hospitalier Pitié‐Salpêtrière Paris France

2. Sorbonne Université Paris France

3. Hematology APHP, Groupe Hospitalier Pitié‐Salpêtrière, Sorbonne Université Paris France

4. Ophthalmology, Institut Curie, Site Paris Université Paris V Descartes et PSL (Paris Science et Lettre) Paris France

5. Hematology, Centre Hospitalier Lyon Sud Université Claude Bernard Lyon 1 Pierre‐Bénite France

6. Ophthalmology, Croix‐Rousse University Hospital Université Claude Bernard Lyon 1 Lyon France

7. Laboratoire UMR‐CNRS 5510 Matéis Université Lyon 1 Lyon France

8. Oncology, Institut Bergonié Bordeaux France

9. Ophthalmology Centre Hospitalier Universitaire de Bordeaux Bordeaux France

10. University of Bordeaux, INSERM Bordeaux France

11. Neuro‐oncology, Assistance Publique – Hôpitaux de Marseille (AP‐HM), Timone Marseille France

12. Aix‐Marseille Université, CRO2, UMR911 Marseille France

13. Ophthalmology Centre Hospitalier Intercommunal Toulon Toulon France

14. Neurology Centre Hospitalier Universitaire de Nancy Nancy France

15. Ophthalmology Centre Hospitalier Universitaire de Nancy, Université de Lorraine Nancy France

16. Hematology Centre Hospitalier Universitaire de Rennes, Université de Rennes, INSERM U1236 Rennes France

17. Ophthalmology Centre Hospitalier Universitaire de Rennes Rennes France

18. Hematology Centre Hospitalier Universitaire de Tours Tours France

19. Ophthalmology Centre Hospitalier Universitaire de Tours Tours France

20. Hematology Centre Hospitalier Universitaire de Angers Angers France

21. Ophthalmology Centre Hospitalier Universitaire de Angers Angers France

22. Hematology Centre Hospitalier Universitaire de Besançon, Hôpital Jean Minjoz Besançon France

23. Ophthalmology Centre Hospitalier Universitaire de Besançon, Hôpital Jean Minjoz Besançon France

24. Neurology Hôpital Pasteur – Hôpitaux Civils de Colmar Colmar France

25. Ophthalmology Hôpitaux civils de Colmar Colmar France

26. Hematology Centre Hospitalier Universitaire de Grenoble Grenoble France

27. Grenoble Alpes University Grenoble France

28. Ophthalmolgy Grenoble Alpes University Hospital Grenoble France

29. Hematology Institut Universitaire du Cancer de Toulouse Oncopôle Toulouse France

30. Ophthalmology Ramonville Saint Agne Toulouse France

31. Hematology Centre Hospitalier Universitaire de Amiens Amiens France

32. Ophthalmology Centre Hospitalier Universitaire de Amiens Amiens France

33. Hematology Centre Hospitalier Universitaire de Brest Brest France

34. Ophthalmology Centre Hospitalier Universitaire de Brest Brest France

35. Hematology Centre Hospitalier Universitaire de Caen, Université de Caen‐Normandie Caen France

36. Ophthalmology, Unicaen Centre Hospitalier Universitaire de Caen Caen France

37. Hematology Centre Hospitalier Universitaire de Clermont‐Ferrand Clermont‐Ferrand France

38. Ophthalmology Centre Hospitalier Universitaire de Gabriel Montpied Clermont‐Ferrand France

39. Hematology, Saint Eloi Hospital Montpellier University Hospital Montpellier France

40. Ophthalmology Centre Hospitalier Universitaire Gui de Chauliac Montpellier France

41. Ophthalmology Centre Hospitalier Universitaire de Nantes Nantes France

42. Hematology APHP, Cochin Hospital Paris France

43. Ophthalmology APHP, Cochin Hospital Paris France

44. Hematology Centre Hospitalier Universitaire de Strasbourg Strasbourg France

45. Ophthalmology Centre Hospitalier Universitaire de Strasbourg Strasbourg France

46. Service d'hématologie biologique APHP, Groupe Hospitalier Pitié‐Salpêtrière Paris France

47. Neurology APHP Sorbonne Université, IHU, ICM, Groupe Hospitalier Pitié‐Salpêtrière Paris France

48. Hematology Institut Curie Site Saint‐Cloud Paris France

49. INSERM U932, Institut Curie, PSL Research University Paris France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26199

Reference42 articles.

1. Primary Vitreoretinal Lymphoma—A Review

2. Primary Central Nervous System Lymphoma

3. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma

4. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse

5. Primary CNS lymphoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma;British Journal of Haematology;2023-12-22

2. Central Nervous System Lymphoma;CONTINUUM: Lifelong Learning in Neurology;2023-12

3. Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis;BMC Ophthalmology;2023-11-22

4. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma;Ophthalmology Retina;2023-11

5. Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514);European Journal of Cancer;2023-08